-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, T3Zmk0lvp+rpCBiOem99hZcWVwF9fx2WkXNUYp4m5MgEkoZZ5VTbNw0ZAJo7wFJN 6yCbsdB+xmN2ejvb/mgEBg== 0000898430-02-000925.txt : 20020510 0000898430-02-000925.hdr.sgml : 20020510 ACCESSION NUMBER: 0000898430-02-000925 CONFORMED SUBMISSION TYPE: POS AM PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20020318 DATE AS OF CHANGE: 20020510 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SYNBIOTICS CORP CENTRAL INDEX KEY: 0000719483 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 953737816 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: POS AM SEC ACT: 1933 Act SEC FILE NUMBER: 333-90493 FILM NUMBER: 02577377 BUSINESS ADDRESS: STREET 1: 11011 VIA FRONTERA CITY: SAN DIEGO STATE: CA ZIP: 92127 BUSINESS PHONE: 6194513771 S-3/A 1 ds3a.txt POST EFFECTIVE AMENDMENT #1 As filed with the Securities and Exchange Commission on March 18, 2002 Registration No. 333-90493 - -------------------------------------------------------------------------------- SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 --------------------------- POST-EFFECTIVE AMENDMENT NO. 1 FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 --------------------------- SYNBIOTICS CORPORATION (Exact name of Registrant as specified in its charter) CALIFORNIA 95-3737816 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) --------------------------- 11011 Via Frontera, San Diego, California 92127 (858) 451-3771 (Address, including zip code, and telephone number, including area code, of Registrant's principal executive offices) --------------------------- Paul A. Rosinack President and Chief Executive Officer SYNBIOTICS CORPORATION 11011 Via Frontera, San Diego, California 92127 (858) 451-3771 (Name, address, including zip code, and telephone number, including area code, of agent for service) --------------------------- Copy to: Hayden J. Trubitt, Esq. BROBECK, PHLEGER & HARRISON LLP 12390 El Camino Real San Diego, California 92130 --------------------------- Approximate date of commencement of proposed sale to the public: From time to time after the effective date of this Registration Statement. --------------------------- If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box. [_] If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box. [X] If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. [_] If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. [_] If delivery of the prospectus is expected to be made pursuant to Rule 434, please check the following box. [_] - -------------------------------------------------------------------------------- SYNBIOTICS CORPORATION Deregistration -------------- This registration statement, as amended to the date of its effectiveness (November 19, 1999), registered 153,846 shares of our common stock. These shares were offered for resale by S.R. One, Limited, who received the shares in connection with our 1996 acquisition of International Canine Genetics, Inc. S.R. One, Limited has not sold any of the shares. As S.R. One, Limited is no longer considered to be an "affiliate" under Rule 144, we are deregistering all of the unsold shares at this time. S.R. One, Limited may continue to sell the shares as may be permitted by Rule 144(k). Accordingly, we hereby deregister 153,846 shares of our common stock originally covered by the registration statement. SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of San Diego, State of California on March 18, 2002. SYNBIOTICS CORPORATION By: /s/ Paul A. Rosinack -------------------- Paul A. Rosinack President and Chief Executive Officer Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated.
Signature Title Date --------- ----- ---- /s/ Paul A. Rosinack Chief Executive Officer, President and March 18, 2002 - ---------------------------------- Director Paul A. Rosinack (Principal Executive Officer) /s/ Michael K. Green Chief Financial Officer and Senior Vice March 18, 2002 - ---------------------------------- President Michael K. Green (Principal Financial Officer) /s/ Keith A. Butler Corporate Controller March 18, 2002 - ---------------------------------- (Principal Accounting Officer) Keith A. Butler /s/ Thomas A. Donelan Director March 18, 2002 - ---------------------------------- Thomas A. Donelan /s/ Christopher P. Hendy Director March 18, 2002 - ---------------------------------- Christopher P. Hendy
-1- -----END PRIVACY-ENHANCED MESSAGE-----